Gene · 3853
Papers1,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The expression pattern of cytokeratin 6a in epithelial cells of different origin in dermo-epidermal skin substitutes in vivo. | Biotechnol J | 2024 | 37766482 | PubTator, text mining | PubMed |
| Younger age is associated with cardiovascular pathological phenotype of severe COVID-19 at autopsy. | Front Med (Lausanne) | 2023 | 38259848 | PubTator, text mining | PubMed |
| Mechanistic analysis of Th2-type inflammatory factors in asthma. | J Thorac Dis | 2023 | 38249931 | PubTator, text mining | PubMed |
| Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma. | J Thorac Dis | 2023 | 38249902 | PubTator, text mining | PubMed |
| Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift. | Front Immunol | 2023 | 38239354 | PubTator, text mining | PubMed |
| Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America. | Front Immunol | 2023 | 38235127 | PubTator, text mining | PubMed |
| Key Factors in the Complex and Coordinated Network of Skin Keratinization: Their Significance and Involvement in Common Skin Conditions. | Int J Mol Sci | 2023 | 38203406 | PubTator, text mining | PubMed |
| AI/ML advances in non-small cell lung cancer biomarker discovery. | Front Oncol | 2023 | 38148837 | PubTator, text mining | PubMed |
| Carrier-Tumor Cell Membrane Interactions for Optimized Delivery of a Promising Drug, 4(RS)-4-F4t-Neuroprostane. | Pharmaceutics | 2023 | 38140081 | PubTator, text mining | PubMed |
| Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer. | Biology (Basel) | 2023 | 38132318 | PubTator, text mining | PubMed |
| Exploring the prognostic value of S100A11 and its association with immune infiltration in breast cancer. | Sci Rep | 2023 | 38129538 | PubTator, text mining | PubMed |
| The search for plausible economic mineral deposits in the central parts of Tanzania; insight from stream sediment geochemistry, multivariate statistics and geostatistics. | Heliyon | 2023 | 38125464 | PubTator, text mining | PubMed |
| UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation. | bioRxiv | 2023 | 38105982 | PubTator, text mining | PubMed |
| Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple-negative breast cancer. | Cancer Innov | 2023 | 38090381 | PubTator, text mining | PubMed |
| The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds. | Int J Mol Sci | 2023 | 38069175 | PubTator, text mining | PubMed |
| Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics. | Front Pharmacol | 2023 | 38044943 | PubTator, text mining | PubMed |
| Unravelling host-pathogen interactions by biofilm infected human wound models. | Biofilm | 2023 | 38025836 | PubTator, text mining | PubMed |
| A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer. | Front Immunol | 2023 | 38022675 | PubTator, text mining | PubMed |
| Molecular Characterisation of Blood Microbiome in Patients with Ankylosing Spondylitis and Healthy Controls. | Med J Islam Repub Iran | 2023 | 38021395 | PubTator, text mining | PubMed |
| Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2023 | 38011564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3853/papers?page=8